Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the sedative-hypnotic drugs market size evolved in recent years?

There has been a robust expansion in the market size of sedative-hypnotic drugs in the past few years. The market, which stood at $3.57 billion in 2024, is projected to escalate to $3.89 billion in 2025, signaling a compound annual growth rate (CAGR) of 9.0%. Several factors contributed to this historical growth, including the growth of direct-to-consumer advertising, a surge in stress levels, a rise in sleep disorder incidence, an increase in direct-to-consumer marketing, and an aging global populace.

What are the predictions for the sedative-hypnotic drugs market size in the coming years?

The sedative-hypnotic drugs market size is expected to see strong growth in the next few years. It will grow to $5.43 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to growing healthcare infrastructure, rising disposable incomes, rising incidence of lifestyle-related disorders, growing consumer interest in natural and herbal sleep aids, and expansion of telemedicine services. Major trends in the forecast period include a growing preference for non-benzodiazepine sedative-hypnotic drugs, innovations in drug delivery technologies, increasing focus on personalized medicine, incorporation of digital health tools, and advent of benzodiazepines.

Get your sedative-hypnotic drugs market report here!

https://www.thebusinessresearchcompany.com/report/sedative-hypnotic-drugs-global-market-report

What key factors are fueling the growth of the sedative-hypnotic drugs market?

As stress levels rise, there’s an anticipated acceleration in the growth of the sedative-hypnotic drugs market. Stress is identified as mental or emotional strain due to inescapable or taxing situations. Balancing personal life with professional duties, lack of effective stress management strategies, and escalating job pressure are all significant contributors to stress. Sedative-hypnotic drugs, predominantly used as pharmacological agents, aim to induce calmness, reduce anxiety, and relieve tension in individuals, largely due to their calming effect on the central nervous system. For example, a survey in December 2022 conducted by the American Psychiatric Association comprising 2,212 American adults stated that over 26% (more than one in four) expected their stress levels to rise at the start of 2023. This was a significant jump from the 20% recorded the previous year. Consequently, these rising stress levels are fuelling the growth of the sedative-hypnotic drugs market.

How is the global sedative-hypnotic drugs market divided into key segments?

The sedative-hypnotic drugs market covered in this report is segmented –

1) By Drug Class: Benzodiazepines, Barbiturates, Antihistamines, Nonbenzodiazepine, Other Drug Classes

2) By Route of Administration: Oral, Parenteral, Other Routes of Administration

3) By Disease Type: Sleep Disorders, Anesthesia, Pain, Other Disease Types

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Benzodiazepines: Diazepam, Lorazepam, Alprazolam

2) By Barbiturates: Phenobarbital, Thiopental, Pentobarbital

3) By Antihistamines: Diphenhydramine, Hydroxyzine

4) By Nonbenzodiazepine: Zolpidem, Eszopiclone, Zaleplon

5) By Other Drug Classes: Melatonin Receptor Agonists, Orexin Receptor Antagonists

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15666&type=smp

Who are the key firms paving the way for growth in the sedative-hypnotic drugs market?

Major companies operating in the sedative-hypnotic drugs market are Sun Pharmaceutical Industries Inc., Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Bayer AG, Novartis AG, Sanofi-Aventis AG, AstraZeneca Plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Mylan N.V., Fresenius Kabi AG, Eli Lilly and Co., Aurobindo Pharma Limited, Cipla Inc., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Pharmaceuticals Inc., Allergan Pharmaceuticals Inc., Glenmark Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd.

What are the key trends shaping the future of the sedative-hypnotic drugs market?

Leading businesses in the sedative-hypnotic drugs market are concentrating their efforts on enhancing their product range through the introduction of innovative items such as sublingual films used in the acute treatment of agitation, in a bid to remain competitive. This sublingual film is a thin dissolvable film with medication which when placed under the tongue can quickly absorb into the bloodstream. For example, BioXcel Therapeutics Inc., a biopharmaceutical firm based in the USA, announced in April 2022, the rollout of IGALMI, a sublingual film purposely designed for treating acute agitation associated with schizophrenia or bipolar I or II disorders in adults. This product marks the first fresh acute treatment for agitation related to schizophrenia or bipolar disorder in nearly ten years, and it introduces an unique treatment modality for patients grappling with this severe and debilitating symptom. The introduction of IGALMI signifies a substantial achievement by providing healthcare teams with a novel method for managing agitation thanks to its fast action and self-administered film format.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15666

What regions are contributing significantly to the growth of the sedative-hypnotic drugs market?

North America was the largest region in the sedative-hypnotic drugs market in 2023. The regions covered in the sedative-hypnotic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Acute Ischemic Stroke Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/acute-ischemic-stroke-drugs-global-market-report

Pancreatic Cancer Drugs Global Market Opportunities And Strategies To 2032

https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-drugs-market

Ophthalmic Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ophthalmic-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: